The mechanism of DNA transmission between distinct organisms has remained a subject of long-standing interest. Agrobacterium tumefaciens mediates the transfer of plant oncogenes in the form of a 25-kb T-DNA sector of a resident Ti plasmid. A growing body of evidence leading to the elucidation of the mechanism involved in T-DNA transfer comes from studies on the vir genes contained in six major operons that are required for the T-DNA transfer process. Recent comparative amino acid sequence studies of the products of these vir genes have revealed interesting similarities between Tra proteins of Escherichia coli F factor, which are involved in the biosynthesis and assembly of a conjugative pilus, and VirB proteins encoded by genes of the virB operon of A. tumefaciens pTiC58. We have previously identified VirB2 as a pilin-like protein with processing features similar to those of TraA of the F plasmid and have shown that VirB2 is required for the biosynthesis of pilin on a flagella-free Agrobacterium strain. In the present work, VirB2 is found to be processed and localized primarily to the cytoplasmic membrane in E. coli. Cleavage of VirB2 was predicted previously to occur between alanine and glutamine in the sequence -Pro-Ala-Ala-Ala-Glu-Ser-. This peptidase cleavage sequence was mutated by an amino acid substitution for one of the alanine residues (D for A at position 45 [A45D]), by deletion of the three adjacent alanines, and by a frameshift mutation 22 bp upstream of the predicted Ala-Glu cleavage site. With the exception of the frameshift mutation, the alanine mutations do not prevent VirB2 processing in E. coli, while in A. tumefaciens they result in VirB2 instability, since no holo-or processed protein is detectable. All of the above mutations abolish virulence. The frameshift mutation abolishes processing in both organisms. These results indicate that VirB2 is processed into a 7.2-kDa structural protein. The cleavage site in E. coli appears to differ from that predicted in A. tumefaciens. Yet, the cleavage sites are relatively close to each other since the final cleavage products are similar in size and are produced irrespective of the length of the amino-terminal portion of the holoprotein. As we observed previously, the similarity between the processing of VirB2 in A. tumefaciens and the processing of the propilin TraA of the F plasmid now extends to E. coli.
Plant transformation by Agrobacterium tumefaciens requires the presence of the Ti plasmid, whose genes mediate the transmission of an oncogene-bearing plasmid sector (T-DNA) from the infecting bacteria to plant cells. The vir genes required for T-DNA processing and transfer are contained in a 29-kb regulon on the Ti plasmid, which is arranged as six major operons in the linear order virA, virB, virG, virC, virD, and virE (20) . The virA and virG gene products are part of a conserved two-component signal transducing system conferring positive transcriptional regulation of the remaining operons (29) . The genes of the remaining operons confer activities essential for the processing and transfer of the 25-kb T-DNA.
These processing and transfer mechanisms have many features in common with conjugational DNA transfer occurring between bacteria. Sequence comparison between vir genes and genes essential for conjugative transfer of plasmids in other bacterial systems have provided valuable insights into the potential roles of the products of these vir genes. The most striking case involves the amino acid sequence identities between the proteins encoded by the virB operon and those known to be involved in the synthesis and assembly of a conjugative pilus, such as the pilus of plasmid F of the plasmid incompatibility group IncFI (12, 22, 23) . Further remarkable similarities have been observed between VirB and VirD proteins and those encoded by plasmid transfer genes of conjugative plasmids (11, 12, (15) (16) (17) (18) 21) and genes involved in secretion of peptide toxin from Bordetella pertussis (3, 21, 27) . The VirB2 protein shares 48% amino acid sequence similarity with TraA of plasmid F. TraA is the propilin protein that is the major constituent of the F conjugative pilus. The products of at least 10 other F tra genes are required for synthesis and assembly of the conjugative-pilus structure (4, 9) . This observation suggested that VirB2 is also a pilin protein that may feasibly form a pilus with the other VirB proteins required for the elaboration and assembly of such a structure, which may facilitate T-DNA transfer (12, 13) . VirB-dependent pili have been observed in a flagellum-free strain of A. tumefaciens (13, 13a) . The results of these sequence studies, along with those of earlier genetic analyses (1, 2, 7, 25) , have strongly implicated a conjugative mechanism for T-DNA transfer from A. tumefaciens to plants.
In F-mediated transfer, the 12.8-kDa propilin protein TraA is processed into a 7.2-kDa N-acetylated F-pilin subunit (4, 9) . Likewise, the 12.3-kDa protein VirB2 appears to be processed into a 7.2-kDa polypeptide (22) . We have investigated the VirB2 processing mechanism further and show in this report that the processing reaction that occurs in A. tumefaciens also occurs in Escherichia coli and that the 12.3-kDa holoprotein remains unprocessed in vitro. We demonstrate that VirB2 cleavage occurs in E. coli irrespective of amino acid substitution and deletion mutations in the putative cleavage site. These mutations cause the complete loss of oncogenicity and protein instability rather than leaving a residual uncleaved product in A. tumefaciens.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. Bacterial strains and plasmids used in this study are described in Table 1 . E. coli BL21(DE3) (26), S17-1 (24) , and DH5␣ (8) were grown at 37ЊC in LB medium (10 g of tryptone [Difco], 5 g of yeast extract, and 3 g of NaCl per liter) with vigorous aeration or on LB containing 1.5% agar. When specified, M9 medium (6 g of Na 2 HPO 4 , 3 g of KH 2 PO 4 , 0.5 g of NaCl, 1 g of NH 4 Cl, 0.1 g of MgSO 4 ⅐ 7H 2 O, and 0.1 g of CaCl 2 per liter with 0.2% glucose; pH 7.4) was also used. A. tumefaciens NT1RE and LBA4301RM, described previously (14) , were grown at 28ЊC in medium 523 ( pJK270 is plasmid pTiC58 containing a Tn5 insertion near the left border of the T-DNA (14) . Plasmid pUCD3432 contains the virB2 gene derived from pUCD2619, which contains the entire vir regulon of pTiC58 (20) . The construction of plasmid pUCD3432 is described in the next section. pUCD3412 contains virB1, virB2, and virB3 genes in pTZ18R (United States Biochemical, Cleveland, Ohio); pUCD4591 contains the promoter of virB, including virB1 and virB2 cloned in pUCD2001 (5) . Plasmid pJQ200SK, containing the original sacB gene from Gay et al. for positive selection (6), was kindly provided by Michael F. Haynes (19) . The expression plasmid pET3a, which was used in the preparation of VirB2 protein, was described previously (26) .
Construction of VirB2 expression plasmids. pUCD3432 was constructed by amplifying the virB2 gene of pUCD2619 by PCR with primers A (5Ј-CGCGGA TCCGCAATAATGCGATGCTT-3Ј) and B (5Ј-CGCGGATCCAGAC GATC ATTCATTAG-3Ј), both of which have BamHI sites incorporated at their termini. The virB2 PCR product was digested with BamHI and inserted and ligated into the BamHI site of pET3a. The correct orientation of the virB2 insert with respect to the phage T7 promoter was verified by restriction endonuclease mapping and sequencing of the recombinant plasmid. The virB2 gene is oriented such that the expression should result in the production of a fusion protein connecting the first 12 amino acids of the T7 gene 10 to VirB2. Protein expression was regulated by using isopropyl-␤-D-thiogalactopyranoside (IPTG) (Research Products, Mt. Prospect, Ill.).
In vitro expression of VirB2. DNAs of virB2 and virB2 derivatives were purified by CsCl density gradient centrifugation and used as the templates for Immunoblot analysis. The production of rabbit-borne polyclonal antibodies to VirB2 and VirB9 was described previously (10) . To detect specific VirB2 expression in E. coli, antibody raised against the VirB2 peptide was cross-absorbed by incubating the antibody with a sonicated E. coli DH10B lysate for 4 h. The cross-absorbed antibody was preserved with 0.05% sodium azide at 4ЊC. The presence of VirB2 and VirB9 proteins in whole-cell extracts, subcellular fractions, and VirB2 synthesized in vitro was determined by immunoblotting (Western blotting) (10) . Specific antiserum reactions were visualized with the ECL chemiluminescence system employing horseradish peroxidase-conjugated donkey antibodies to the VirB2 rabbit antibodies (Amersham, Arlington Heights, Ill.).
Pulse-chase analysis. E. coli BL21(DE3)(pLysS) cells containing either pUCD3432, pUCD4726, pUCD4598, pUCD4743, or pET3a were grown in M9 minimal medium with appropriate antibiotics at 37ЊC to early log phase. Cells in early log phase were induced with IPTG at a final concentration of 1 mM for 1 h and then treated with rifampin (100 g/ml) for an additional 1 h. The cells were then labelled with 10 Ci of [
35 S]methionine for 1 min, and 250 l of the cell suspension was centrifuged at 10,000 ϫ g for 2 min. Two volumes of fresh M9 medium containing 1.2 mM unlabelled L-methionine were added to the remaining labelled culture, and 750-l aliquots were removed at timely intervals until 2 h after addition of the label. The labelled cells were collected by centrifugation at 10,000 ϫ g for 2 min and quickly frozen in a solid CO 2 -ethanol bath. The cells were thawed, resuspended in 50 l of Tricine solubilization buffer (Bio-Rad, Hercules, Calif.), and placed in a boiling water bath for 5 min. The solubilized proteins were fractionated by SDS-PAGE and autoradiographed.
Site-directed mutagenesis and gene replacement. Site-directed mutagenesis employing oligonucleotides was carried out according to the supplier of the Mutagene kit (Bio-Rad, Richmond, Calif.). The oligonucleotide 5Ј-TTCTCCT CTGGGCCGCAA TCTGCAGGTGGC-3Ј was used in the construction of B2D45AAA47, and 5Ј-GGGCCGGACGCGGCCCAATCT-3Ј was employed in the construction of B2A45D. The template plasmid for mutagenesis was pUCD3412, generating pUCD4596 (with a substitution of D for A at position 45 [A45D]) and pUCD4597 (AAA deleted). The mutations were confirmed by nucleotide sequencing. Markerless gene replacement, which was used to introduce these mutations into the whole Ti plasmid, required pJQ200SK and is described in Results.
Membrane fractionation. As described previously (10, 22, 23) , cells from 500 ml of culture were suspended in 10 ml of solution A {25 mM HEPES (N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid [pH 7.6]), 2 g of sucrose, 0.2 M KCl, 0.2 mM dithiothreitol, 0.2 mg of DNase per ml, 0.2 mg of RNAse A per ml} and passed through a French pressure cell at 16,000 lb/in 2 three times. Lysozyme (5 mg) was then added to the cracked cells, which were then mixed and incubated on crushed ice for 30 min. Cell debris was removed by centrifugation (2,000 ϫ g, 10 min, 4ЊC), and the supernatant was recentrifuged (110,000 ϫ g, 1 h, 4ЊC) to pellet the membrane fraction. The supernatant was discarded, and the pellet was . Over the suspension was layered 1.0 ml of 70% sucrose in 5 mM EDTA, pH 7.5, and then 3.0 ml of 53% sucrose in 5 mM EDTA, pH 7.5. The discontinuous gradient was centrifuged (100,000 ϫ g, 15 h, 4ЊC) and fractionated into subcellular components (22, 23) .
RESULTS
VirB2 is processed in E. coli. Previously, we examined the production of the VirB2 protein as part of a study in which various virB nonpolar mutants were analyzed with respect to interdependencies between VirB proteins for specific membrane associations (10) . The virB mutations examined had no effect on the accumulation of VirB2 protein, but in all cases, Western blot analyses revealed the presence of a 7.2-kDa protein rather than the 12.3-kDa protein predicted from its open reading frame (22) . This suggested that VirB2 might be processed by a specific peptidase in A. tumefaciens. The specificity of this reaction was therefore studied in the absence of A. tumefaciens gene products by producing the VirB2 protein in E. coli. Plasmid pUCD3432, containing the virB2 gene under the control of a T7 gene 10 promoter, was transformed in E. coli BL21(DE3), and the VirB2 protein was analyzed in four randomly selected transformants. Samples were taken at time points before and after induction with IPTG, and the proteins were fractionated by SDS-PAGE and analyzed by Western blotting with VirB2-specific antisera. When extracts of E. coli containing pUCD3432 were analyzed, a 7.2-kDa protein was observed even in the absence of IPTG induction (Fig. 1) . Expression of the T7 polymerase gene in BL21(DE3) is controlled by the lacUV promoter, which is not tightly regulated; hence, the presence of VirB2 in the uninduced sample is not surprising. The predicted size of VirB2 is 12.3 kDa, while that of the VirB2 fusion protein (joined with the first 12 amino acids of the T7 gene 10; see Materials and Methods) is 13.8 kDa; yet, VirB2 is detected as a 7.2-kDa product. This result suggests that VirB2 is specifically cleaved in E. coli, with an end product similar in size to that produced in A. tumefaciens. That is, since in E. coli the VirB2 protein is expressed and processed in the absence of both Ti plasmid genes and A. tumefaciens chromosomal genes, there is apparently a signal peptidase in E. coli which recognizes a signal sequence in VirB2 to generate the 7.2-kDa product.
Location of VirB2 protein in E. coli. Our previous studies on the subcellular localization of VirB proteins in A. tumefaciens showed that the 7.2-kDa VirB2 protein is associated primarily with the inner membrane but is also associated, albeit at much lower concentrations, with the outer membrane (22) . In the present work with E. coli, the processed 7.2-kDa VirB2 protein is also associated with both the inner and outer membranes, with greater association occurring with the inner membrane than with the outer membrane fraction (Fig. 2) . Thus, the similarities in VirB2 processing extend to similar subcellular localization of the processed protein.
Alteration of the signal peptidase cleavage site affects VirB2 accumulation and virulence. Previously, cleavage of VirB2 in A. tumefaciens was predicted to occur between alanine and glutamine in the sequence -Pro-Ala-Ala-Ala-Glu-Ser-(residues 44 to 49) of the VirB2 holoprotein (22) . Mutant clones pUCD4726, encoding VirB2 with a substitution of Asp at Ala-45 (A45D); pUCD4743, encoding VirB2 with the three adjacent alanine residues removed; and pUCD4598, containing a frameshift mutation, were placed under the control of the T7 gene 10 promoter by subcloning the mutant genes into pET3a. When pUCD4726 was expressed in E. coli BL21(DE3) (pLysS) and the resulting proteins were fractionated by SDS-PAGE, the mutant VirB2 was detected by immunoblotting (Fig. 3) . Likewise, analysis of pUCD4743 produced proteins of the same size. On the other hand, pUCD4598, bearing a frameshift mutation, did not produce VirB2 (Fig. 3) . We interpret these results as showing that the peptidase cleavage occurs close to (owing to the size of the processed product) and includes the three alanine residues.
To determine the effects of these mutations in A. tumefaciens, each mutant virB2 gene was introduced into the TiC58 plasmid pJK270, harbored in strain NT1RE, by reciprocal double recombination as follows. A 2-kb SacI-PvuII DNA fragment including the mutated portion of the virB2 gene was cloned into the SacI and SmaI sites in pJQ200SK DNA to form Wild-type and mutant VirB2 was expressed in E. coli cells induced (ϩ) with IPTG. Uninduced (Ϫ) cells show no VirB2 production. The frameshift mutant pUCD4598 also does not produce VirB2, while VirB2 bearing the A45D and ⌬AAA mutations (pUCD4726 and pUCD4743, respectively) was still processed. Molecular mass markers (M) are shown to the right of each panel.
pUCD4605 and pUCD4606, respectively. pJQ200SK allows for positive selection for double-crossover recombination by virtue of the sacB gene conferring sucrose sensitivity (6, 19) . E. coli S17-1 was transformed with the plasmids individually, and the resulting transformants were mated with A. tumefaciens NT1RE(pJK270) overnight on LB agar. Gentimicin-resistant, sucrose-sensitive transconjugants were recovered by first plating them on LB agar containing gentimicin, then growing them without selection for 20 generations in LB medium, and then plating them on LB agar containing 5% sucrose. Colonies that were sucrose resistant and gentimicin sensitive had undergone double recombination, and the insertion of either mutant virB2 gene into pJK270 was confirmed by restriction mapping (data not shown).
Analysis of protein extracts from A. tumefaciens NT1RE containing either pUCD4605 or pUCD4606 revealed that there was no detectable VirB2, either as a holoprotein or the processed protein (Fig. 4) . As a control, we included a pJK270 derivative that had undergone the double-recombination process but had not incorporated a mutation. Here, the VirB2 protein is detected as expected (Fig. 4, lane 3) . Virulence conferred by pUCD4605 and pUCD4606 was completely abolished, and each of these virB2 mutant plasmids could be complemented with pUCD4591 containing virB2 (Fig. 5) . The predicted peptidase cleavage sequence is therefore critically needed in the VirB2 processing step that leads to T-DNA transfer (as judged by the virulence assays).
Kinetics of VirB2 processing in E. coli. The processing of VirB2 in E. coli was monitored as a function of time. The three virB2 mutant products were labelled for 1 min with [
35 S]methionine and then chased with excess unlabelled L-methionine after 1 h of IPTG induction followed by 1 h of rifampin treatment in M9 medium. As shown in Fig. 6 , VirB2 processing took place with pUCD4726 and pUCD4743 within 1 min. No processing was observed with pUCD4598, which contains the frameshift mutation 22 bp upstream of the putative cleavage site AAA2Q. These results verify the above-cited observation that VirB2 lacking the three alanine residues or containing an amino acid substitution is still recognized by the signal peptidase in E. coli.
Holo-VirB2 protein is produced in vitro. To verify our hypothesis that the virB2 gene product is processed into a 7.2-kDa protein, both the wild-type and mutant virB2 genes were analyzed in vitro for their respective products in a coupled transcription-translation system. As shown in Fig. 7 , the virB2 gene cloned in pUCD3432 is fully expressed as a 13.8-kDa predicted fusion product (lane 1). A protein of the same size appears with the virB2 mutants bearing the site-specific amino acid substitution mutation (A45D) (lane 2). When pUCD4743 encoding VirB2 lacking the three alanine residues was examined, a protein slightly smaller than the 13.8-kDa product was observed, presumably because of shortening of the protein by the removal of these residues (lane 3). Analysis of the frameshift mutant pUCD4598 showed the presence of the 13.8-kDa protein, but the VirB2 protein could not be detected with VirB2 antiserum that recognizes the amino-terminal sequence of the processed 7.2-kDa protein, most likely because a heterologous protein was produced in its place (Fig. 7B, lane 4) . The vector pET3a alone did not produce a 13.8-kDa protein (lane 5). Hence, in vitro, the virB2 gene encodes a full-length protein product that remains unprocessed.
DISCUSSION
The VirB2 protein displays strong amino acid sequence homology (48% identity) to the TraA propilin encoded by the traA gene of plasmid F (22) . The similarity also extends to other Tra proteins involved in the conjugative transfer of Fplasmid DNA. For example, VirB4 and TraC (23), VirB3 and TraL (22) , VirB5 and TraE (12) , and VirB10 and TraB (12) are all involved in the assembly of the F conjugative pilus provided by the TraA pilin structural gene (4, 9, 28) . These similarities also extend to protein processing, with the VirB2 protein being cleaved like TraA propilin, resulting in a 7.2-kDa product like that observed with F propilin. Like TraA, VirB2 is also localized primarily to the inner (cytoplasmic) membrane (22) . The overall similarities, both in structure and function, provide a strong argument that VirB2 encodes as a T-DNA transfer apparatus a conjugative pilus-like structure, as predicted previously (12, 13, 22) . Indeed, our recent studies on a flagella-free strain have revealed the presence of pili whose appearance is dependent on virB2 (13, 13a) . At least two pilus types are produced; one is a long, thin pilus, while the other is a rather thick, stiff pilus, much like that produced by IncW plasmid pSa (13, 13a) .
In the present work, we find that VirB2 is also processed in E. coli and is localized primarily to the inner membrane. The cleavage reaction is specific and remains unaltered even in the presence of 12 additional amino acid residues (originating from T7 gene 10) attached to the amino terminus of VirB2, generating a fusion protein of slightly larger size than that of VirB2 itself. Yet, as in A. tumefaciens (22) , the processed end product generated in E. coli is a 7.2-kDa polypeptide.
Alteration of the predicted signal peptidase sequence -ProAla-Ala-Ala-Glu-Ser-(residues 44 to 49) by a single amino acid substitution (A45D) or by deletion of the three alanine residues results in the complete loss of virulence of A. tumefaciens. We also find from these studies that rather than causing the appearance of an unprocessed holoprotein, either mutation causes the loss of VirB2 protein in vivo in A. tumefaciens. On the other hand, in E. coli, the A45D substitution and AAA deletion mutations did not affect either the production of the holoprotein or its processing. The absence of a processed protein or holoprotein in A. tumefaciens suggests that there may be protein degradation occurring when VirB2 contains these mutations. In E. coli, on the other hand, the processing reaction remains unaffected by these mutations, which suggests that the signal peptidase cleavage site differs from that recognized by a signal peptidase in Agrobacterium cells.
With the F-plasmid pilin synthesis and assembly system, the TraA propilin is processed into a 7.2-kDa pilin subunit before its congregative assembly into a conjugative pilus. Additional genes encoding a transacetylase (TraX) and a pilus maturation factor (TraQ) are required for final pilus assembly (4, 9) . Such enzymes and factors have not been identified for the VirB2 system, and they may or may not be required. Further analysis of the N-terminal sequence of the processed VirB2 protein should shed some light on whether or not the N-terminal amino acid is capped with an acetyl group. The recalcitrant nature of the N terminus with regard to sequencing seems to suggest this (14a).
